Trial intelligence / Profile preview

Xiaflex vs. Palmar Fasciectomy in Dupuytren's Disease (EXTEND)

NCT02725528Phase 3Completed

Sponsor
McMaster University
Start
Jul 2017
Primary completion
Dec 2021
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of collagenase clostridium histolyticum in Dupuytren's disease, sponsored by McMaster University. Started Jul 2017; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's disease

Beyond the preview

Go deeper on NCT02725528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02725528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call